STEM Biomedical welcomes new board member
Wilfrid Laurier University alumnus Filip Lup joins STEM Biomedical as director of finance. Filip will play a pivotal role in boosting the organization's financial capacity in the years to come. This boost on the financial front is greatly needed in order to accelerate research and development. STEM Biomedical considers financial strategy an integral component of fulfilling our goal for the advancement of biomedical research towards the betterment of human health. We look forward to working with Filip to strive towards this goal.
Presentation at Canadian Association for Neuroscience (CAN-ACN) Conference
STEM Biomedical members Alexander Ille, Mathias Moise, and Raoul Bodea co-presented at the 2019 CAN-ACN conference, along with colleagues from D'Youville College. The poster presentation detailed a project centered around structural insights into the alpha-synuclein protein and its mutational variants (pictured right). Alpha-synuclein is recognized as the key pathogenic protein in both familial and sporadic Parkinson's disease. Structural characterization involved in disease is important for the development of novel therapeutics.
Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311. UCSF Chimera--a visualization system for exploratory research and analysis. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. J Comput Chem. 2004 Oct;25(13):1605-12.